The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Pomegranate and PSA in prostate cancer

    The first clinical trial of pomegranate juice in patients with prostate cancer reported a “significant prolongation of PSA [prostate-specific antigen] doubling time” from 15 to 54 months among men with a rising PSA following surgery or radiation for prostate cancer. This was accompanied by other positive changes at the cellular level, according to the researchers from the David Geffen School of Medicine in the July issue of Clinical Cancer Research.

    The results are interesting and will be followed by a placebo-controlled study. But perhaps of greater interest is the fact that this research was sponsored by a California company that, according to the August 7th issue of Newsweek, spends more on funding research than advertising.

    That’s good news. In addition to being the market leader in sales of this odd fruit, the makers of POM Wonderful are setting an example of corporate responsibility for the rest of the nutraceutical and supplement industry.

    8/1/06 08:17 JR

    Leave a Comment

    You must be logged in to post a comment.